TME-SW
01698
NTES-S
09999
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Dec 31, 2024 | (Q3)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q9)Mar 31, 2024 | (Q6)Dec 31, 2023 | (Q3)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q9)Mar 31, 2023 | (Q6)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 25.04%642.39M | 36.50%314.5M | 12.23%1.13B | 9.95%811.1M | 8.87%513.75M | -24.95%230.4M | -32.03%1.01B | --737.7M | -33.87%471.91M | --307M |
Operating income | 25.04%642.39M | 12.23%1.13B | 8.87%513.75M | -32.03%1.01B | -33.87%471.91M | |||||
Cost of sales | -29.43%-521.9M | ---- | -5.17%-874.67M | ---- | -5.30%-403.23M | ---- | 31.13%-831.68M | ---- | 34.61%-382.94M | ---- |
Operating expenses | -29.43%-521.9M | -5.17%-874.67M | -5.30%-403.23M | 31.13%-831.68M | 34.61%-382.94M | |||||
Gross profit | 9.02%120.49M | 45.71%255.49M | 24.22%110.52M | -35.99%175.34M | -30.52%88.97M | |||||
Selling expenses | -63.02%-27.13M | ---- | -26.89%-37.07M | ---- | -10.37%-16.64M | ---- | 22.34%-29.21M | ---- | 19.63%-15.08M | ---- |
Administrative expenses | -0.69%-108.55M | ---- | 3.17%-220.97M | ---- | -11.42%-107.81M | ---- | 1.24%-228.21M | ---- | 13.46%-96.76M | ---- |
Special items of operating profit | -11.23%10.99M | ---- | 41.78%21.82M | ---- | 23.43%12.38M | ---- | -13.55%15.39M | ---- | 0.22%10.03M | ---- |
Operating profit | -171.71%-4.21M | 128.90%19.27M | 87.94%-1.55M | -389.33%-66.69M | -271.30%-12.83M | |||||
Financing cost | -44.70%-12.25M | ---- | -53.90%-19.04M | ---- | -92.01%-8.46M | ---- | -56.93%-12.37M | ---- | -44.90%-4.41M | ---- |
Share of profits of associates | -13.88%180K | ---- | -59.71%361K | ---- | -31.25%209K | ---- | 128.57%896K | ---- | 92.41%304K | ---- |
Share of profit from joint venture company | 14.59%2.11M | ---- | 86.87%3.54M | ---- | 91.29%1.84M | ---- | -48.17%1.9M | ---- | -55.84%964K | ---- |
Earning before tax | -77.91%-14.16M | 105.43%4.14M | 50.18%-7.96M | -496.91%-76.27M | -335.22%-15.97M | |||||
Tax | -2.41%-1.61M | ---- | -17.04%-2.64M | ---- | 9.01%-1.58M | ---- | 70.83%-2.25M | ---- | 27.33%-1.73M | ---- |
After-tax profit from continuing operations | -65.44%-15.77M | 101.91%1.5M | 46.15%-9.53M | -783.53%-78.52M | -501.56%-17.71M | |||||
Earning after tax | -65.44%-15.77M | 101.91%1.5M | 46.15%-9.53M | -783.53%-78.52M | -501.56%-17.71M | |||||
Minority profit | -41.98%2M | ---- | -40.29%3.71M | ---- | -43.88%3.45M | ---- | -21.79%6.21M | ---- | 55.14%6.14M | ---- |
Profit attributable to shareholders | -36.92%-17.77M | 97.40%-2.21M | 45.57%-12.98M | -2,486.82%-84.73M | -5,399.33%-23.85M | |||||
Basic earnings per share | -36.89%-0.059 | 97.51%-0.007 | 45.58%-0.0431 | -2,441.67%-0.281 | -5,380.00%-0.0792 | |||||
Diluted earnings per share | -36.89%-0.059 | 97.51%-0.007 | 45.58%-0.0431 | -2,441.67%-0.281 | -5,380.00%-0.0792 | |||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | -- | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.